Chronic Obstructive Pulmonary Disease (COPD) Treatments

Find Chronic Obstructive Pulmonary Disease (COPD) Treatments

Generic Name

Salmeterol

Brand Names

Advair Diskus, Advair HFA, AirDuo RespiClick, Salmeterol Diskus, Salmeterol HFA, SEREVENT Diskus, Wixela Inhub

FDA approval date: November 25, 1997

Classification: Corticosteroid

Form: Aerosol, Powder

What is Advair Diskus (Salmeterol)?

ADVAIR DISKUS is a combination product containing a corticosteroid and a long-acting beta 2 -adrenergic agonist indicated for: Twice-daily treatment of asthma in patients aged 4 years and older.

Approved To Treat

Top Global Experts

View All

Save this treatment for later

Not sure about your diagnosis?

Check Your Symptoms

Tired of the same old research?

Check Latest Advances

Related Clinical Trials

A Randomized, Phase 2, Double-blind, Placebo-controlled, Parallel-group, 2-arm Study to Investigate the Efficacy, Safety, and Tolerability of Subcutaneous Lunsekimig (SAR443765) in Adult Participants With High-risk Asthma Who Are Not Currently Eligible for Biologic Treatment

Enrollment Status: Recruiting

Publish Date: June 15, 2026

Intervention Type: Drug

Study Phase: Phase 2

Summary: This is a parallel-group, Phase 2, randomized, double-blind, placebo-controlled, 2-arm study for the treatment of asthma. The purpose of this study is to assess the efficacy, safety, and tolerability of add-on therapy with subcutaneous (SC) lunsekimig compared with placebo in male and female participants (aged 18 to 80 years, inclusive) with asthma, who are not currently eligible for biologic trea...

Double-Blinded, Placebo-Controlled, Randomized, 2 Period, Crossover Phase 1/2a Study Testing Safety/Efficacy of Advair HFA (Salmeterol, Fluticasone) in Resting & Exercising Healthy & High Altitude Pulmonary Edema (HAPE) Predisposed Subjects

Enrollment Status: Recruiting

Publish Date: September 22, 2025

Intervention Type: Drug

Study Phase: Phase 1/Phase 2

Summary: The current protocol is composed of two studies. The first study is designed to carefully evaluate the safety of high-dose salmeterol/fluticasone (Advair HFA) versus placebo (hydrofluoroalkane, HFA) administration over 7 days, as well as the efficacy of the study drug to increase exercise performance, in healthy individuals exercising under hypoxic, simulated high-altitude conditions (Phase 1/2a s...

The Muscle Anabolic Response to β2-adrenergic Stimulation

Enrollment Status: Recruiting

Publish Date: April 09, 2025

Intervention Type: Drug

Study Phase: Not Applicable

Summary: The purpose of the project is to investigate the muscle anabolic response to acute beta2-adrenergic stimulation in young healthy men and women.

View All Clinical Trials